(Seoul = Yonhap News) Reporter Shin Seon-mi = SK Biopharmaceuticals [326030] announced that it has signed a strategic memorandum of understanding (MOU) with Europharma regarding the new epilepsy drug 'Cenobamate'...
(Seoul = Yonhap News) Reporter Shin Seon-mi = SK Biopharmaceuticals [326030] announced that it has signed a strategic memorandum of understanding (MOU) with Europharma regarding the new epilepsy drug 'Cenobamate'...